Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The drug giant is hoping to boost its innovation pipeline with new funding for early-stage biotechnology research.
Tiny Trojan horses deliver a cancer drug to cell nuclei.
Researchers watch fluorescent nanoparticles move through the respiratory system, an advance that could lead to better drugs.
A drugmaker is testing an alternative to diabetes injections, but many sizable hurdles remain.
A number of dual-action antibodies are in clinical trials for fighting cancer.
Fragments of known drugs could lead to a more robust antiviral for H1N1 and other flu variants.
Illegitimate pharmacies account for 90 percent of drug ads on Microsoft’s Bing, according to a new report.
The first artificial cell organelle may help researchers find a way to make bioengineered heparin and other synthetic drugs.